TD Asset Management
KITE

TD Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

TD Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-29,986
Closed -$5.39M – 1388
2017
Q3 		$5.39M Sell
29,986
-70,264
-70% -$9.79M 0.01% 643
2017
Q2 		$10.4M Buy
100,250
+38,700
+63% +$3.16M 0.02% 513
2017
Q1 		$4.83M Buy
61,550
+36,800
+149% +$2.28M 0.01% 696
2016
Q4 		$1.11M Buy
24,750
+11,100
+81% +$544K ﹤0.01% 1002
2016
Q3 		$762K Buy
13,650
+7,550
+124% +$421K ﹤0.01% 1072
2016
Q2 		$305K Buy
+6,100
New +$300K ﹤0.01% 1249

TD Asset Management's KITE Position: Q4 2017 in Review

TD Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 29,986 shares — an estimated $5.39M sold.

TD Asset Management first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $10.4M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • TD Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • TD Asset Management sold 29,986 Kite Pharma, Inc. shares in Q4 2017, an estimated $5.39M.
  • TD Asset Management first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
  • TD Asset Management's Kite Pharma, Inc. position peaked at $10.4M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on TD Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.